Functional genomics: paving the way for more successful cancer immunotherapy

被引:5
|
作者
Ajina, Reham [1 ]
Zamalin, Danielle [2 ]
Weiner, Louis M. [3 ,4 ,5 ]
机构
[1] Georgetown Univ, Tumor Biol, Washington, DC 20057 USA
[2] Georgetown Univ, Washington, DC 20057 USA
[3] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr LCCC, Washington, DC 20057 USA
[4] Dept Oncol, Washington, DC USA
[5] MedStar Georgetown Canc Inst, Washington, DC USA
关键词
cancer; functional genomics; immunotherapy; checkpoints; immunity; T-CELL-RECEPTOR; CLONAL EXPANSION; PD-L1; EXPRESSION; OPEN-LABEL; TUMOR; IPILIMUMAB; RESISTANCE; MECHANISMS; BLOCKADE; PEMBROLIZUMAB;
D O I
10.1093/bfgp/ely017
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Immunotherapies have revolutionized cancer treatment. Immunotherapy is effective for the treatment of a wide range of cancer types and can mediate complete and durable tumor regression. Nonetheless, the field still faces many significant challenges, such as the need for personalized therapeutic strategies and better biomarkers, the difficulty of selecting the right combination therapy, and resistance to currently available immunotherapies. Both cancer and host immunity comprise significantly diverse and complex ecosystems, making immunogenomics an ideal field for functional genomics analysis. In this review, we describe the cancer-immunity cycle, how cancer cells manage to evade immune attack and the current hurdles in the path of cancer immunotherapy. Then, we discuss how functional genomics approaches can pave the way for more successful cancer immunotherapies.
引用
收藏
页码:86 / 98
页数:13
相关论文
共 50 条
  • [21] Functional genomics of cancer
    Liu, Edison T.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (03) : 251 - 256
  • [22] Understanding the relationship between gliomas and T cells: Paving the way for effective immunotherapy
    Lee-Chang, Catalina
    NEURO-ONCOLOGY, 2022, 24 (10) : 1658 - 1659
  • [23] CAR designs for solid tumors: overcoming hurdles and paving the way for effective immunotherapy
    Yuanbin Cui
    Mintao Luo
    Chuanyuan Gu
    Yuxian He
    Yao Yao
    Peng Li
    Biophysics Reports, 2023, 9 (05) : 279 - 297
  • [24] Successful engineering cancer immunotherapy
    Romero, Pedro
    Coukos, George
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (02) : 318 - 320
  • [25] Chasing on the way of cancer immunotherapy
    Wu, Licun
    JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : E137 - E138
  • [26] Ruthenium new drug: paving the way for cancer therapy
    Garcia, Maria Helena
    Valente, Andreia
    Morais, Tania S.
    Tomaz, Ana Isabel
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2017, 22 : S122 - S122
  • [27] Phosphatidylserine: paving the way for a new era in cancer therapies
    Preetam, Subham
    Pandey, Arunima
    Mishra, Richa
    Mohapatra, Gautam
    Rath, Pratyasa
    Malik, Sumira
    Rustagi, Sarvesh
    Dash, Alisha
    Samal, Shailesh Kumar
    MATERIALS ADVANCES, 2024,
  • [28] Paving the Way for Cancer Therapy a Nano Step at a Time
    Venkatesh, Divya
    Merghoub, Taha
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 384 (03): : 327 - 330
  • [29] Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges
    Pramod K. Srivastava
    Fei Duan
    Cancer Immunology, Immunotherapy, 2013, 62 : 967 - 974
  • [30] Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges
    Srivastava, Pramod K.
    Duan, Fei
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (05) : 967 - 974